Changes for page Sanofi India Ltd

Last modified by Asif Farooqui on 2021/08/25 13:43
From version < 12.1 >
edited by Asif Farooqui
on 2021/08/23 13:51
To version < 13.1
edited by Asif Farooqui
on 2021/08/25 13:43
<
Change comment: There is no comment for this version

Summary

Details

Page properties
Tags
... ... @@ -1,1 +1,1 @@
1 -IN:Sanofi
1 +IN:SANOFI
Content
... ... @@ -7,7 +7,7 @@
7 7  * Sanofi India is 100% subsidiary of Hoechst GmbH a world's leading healthcare companies
8 8  * Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market.
9 9  * It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.
10 -* The company's healthcare solutions are available 170 countries
10 +* The company's healthcare solutions are available in 170 countries
11 11  
12 12  [[image:Sanofi0.jpg||height="388" width="689"]]
13 13  
... ... @@ -62,8 +62,6 @@
62 62  
63 63  [[image:Sanofi4.jpg]]
64 64  
65 -{{putFootnotes/}}
66 -
67 67  = Industry Overview =
68 68  
69 69  From 9% CAGR seen until 2019 (over previous 4 years), the unprecedented impact of COVID-19 on the Indian Pharmaceuticals Industry, resulted in subdued performance with annual industry value growth plummeting to 4.4% in year 2020. For the year ended 31st December 2020, IQVIA estimated the Indian Pharmaceuticals Market size to be Rs.1,535 billion.{{footnote}}https://www.sanofiindialtd.com/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-INLTD/Home/Investors/annual-reports/Annual-Report-2020.pdf?la=en{{/footnote}}
This site is funded and maintained by Fintel.io